Literature DB >> 19389549

Autoantibody profiling for cancer detection.

Ji Qiu1, Sam Hanash.   

Abstract

Despite substantial progress in the understanding of the pathogenesis of cancer, the development and implementation of strategies for early cancer detection have lagged behind. Harnessing the immune response to tumor antigens is particularly useful for early detection because the immune response occurs early during tumor development and affords signal amplification with the end product, namely reactive immunoglobulins, being released into the circulation allowing easy access through the blood. This article presents recent developments in autoantibody profiling with a focus on proteomic approaches and applications to lung cancer.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19389549     DOI: 10.1016/j.cll.2009.01.002

Source DB:  PubMed          Journal:  Clin Lab Med        ISSN: 0272-2712            Impact factor:   1.935


  13 in total

1.  Electrophilic affibodies forming covalent bonds to protein targets.

Authors:  Lotta Holm; Paul Moody; Mark Howarth
Journal:  J Biol Chem       Date:  2009-09-15       Impact factor: 5.157

2.  Immunoprofiling using NAPPA protein microarrays.

Authors:  Sahar Sibani; Joshua LaBaer
Journal:  Methods Mol Biol       Date:  2011

3.  Peptide ligand-based ELISA reagents for antibody detection.

Authors:  Ewa Heyduk; Rachel Hickey; Nicola Pozzi; Tomasz Heyduk
Journal:  Anal Biochem       Date:  2018-08-18       Impact factor: 3.365

4.  Rapid isolation of high-affinity human antibodies against the tumor vascular marker Endosialin/TEM1, using a paired yeast-display/secretory scFv library platform.

Authors:  Aizhi Zhao; Selene Nunez-Cruz; Chunsheng Li; George Coukos; Don L Siegel; Nathalie Scholler
Journal:  J Immunol Methods       Date:  2010-09-15       Impact factor: 2.303

Review 5.  TAA polyepitope DNA-based vaccines: a potential tool for cancer therapy.

Authors:  Roberto Bei; Antonio Scardino
Journal:  J Biomed Biotechnol       Date:  2010-06-17

6.  µFBI: a microfluidic bead-based immunoassay for multiplexed detection of proteins from a µL sample volume.

Authors:  Xiaobo Yu; Michael Hartmann; Quan Wang; Oliver Poetz; Nicole Schneiderhan-Marra; Dieter Stoll; Cornelia Kazmaier; Thomas O Joos
Journal:  PLoS One       Date:  2010-10-01       Impact factor: 3.240

7.  Selenium-Binding Protein 1 (SBP1) autoantibodies in ovarian disorders and ovarian cancer.

Authors:  Yi Yu-Rice; Seby L Edassery; Nicole Urban; Ingegerd Hellstrom; Karl Erik Hellstrom; Youping Deng; Yan Li; Judith L Luborsky
Journal:  Reproduction       Date:  2016-12-13       Impact factor: 3.906

8.  Proteomic profiling of the autoimmune response to breast cancer antigens uncovers a suppressive effect of hormone therapy.

Authors:  Timothy Chao; Jon J Ladd; Ji Qiu; Melissa M Johnson; Rebecca Israel; Alice Chin; Hong Wang; Ross L Prentice; Ziding Feng; Mary L Disis; Samir Hanash
Journal:  Proteomics Clin Appl       Date:  2013-05-10       Impact factor: 3.494

9.  An integrated genome-wide approach to discover tumor-specific antigens as potential immunologic and clinical targets in cancer.

Authors:  Qing-Wen Xu; Wei Zhao; Yue Wang; Maureen A Sartor; Dong-Mei Han; Jixin Deng; Rakesh Ponnala; Jiang-Ying Yang; Qing-Yun Zhang; Guo-Qing Liao; Yi-Mei Qu; Lu Li; Fang-Fang Liu; Hong-Mei Zhao; Yan-Hui Yin; Wei-Feng Chen; Yu Zhang; Xiao-Song Wang
Journal:  Cancer Res       Date:  2012-11-07       Impact factor: 12.701

10.  Immune-Signatures for Lung Cancer Diagnostics: Evaluation of Protein Microarray Data Normalization Strategies.

Authors:  Stefanie Brezina; Regina Soldo; Roman Kreuzhuber; Philipp Hofer; Andrea Gsur; Andreas Weinhaeusel
Journal:  Microarrays (Basel)       Date:  2015-04-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.